Challenges in early phase clinical trials for childhood cancer during the COVID-19 pandemic: a report from the new agents group of the Spanish Society of Paediatric Haematology and Oncology (SEHOP).
A Rubio-San-SimónJ Verdú-AmorósR HladunA Juan-RibellesM MoleroP Guerra-GarcíaA Pérez-MartínezA CastañedaA CañeteT de RojasL MorenoFrancisco J Bautista SirventPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2020)
The COVID-19 crisis has significantly impacted clinical research practice and access to innovation for children with cancer. Structural and functional changes are under way to better cope with the expected future restrictions.
Keyphrases
- childhood cancer
- young adults
- clinical trial
- coronavirus disease
- sars cov
- public health
- healthcare
- intensive care unit
- palliative care
- primary care
- emergency department
- current status
- papillary thyroid
- quality improvement
- open label
- squamous cell carcinoma
- phase ii
- lymph node metastasis
- phase iii
- respiratory syndrome coronavirus